The intraperitoneal administration of an anti-CD137 monoclonal antibody eliminated tumors that were established via subcutaneous inoculation of Agl04A sarcoma or 10815 mast cells in mice on the third and seventh day after inoculation, respectively [25]. This evidence concerns the gene TNFRSF9 and sarcoma.